KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed (2018 - 2025)

Teva Pharmaceutical Industries' Return on Capital Employed history spans 8 years, with the latest figure at 0.08% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 9.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Dec 2025, up 9.0%, and an annual FY2025 reading of 0.08%, up 9.0% over the prior year.
  • Return on Capital Employed for Q4 2025 was 0.08% at Teva Pharmaceutical Industries, up from 0.06% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.08% in Q4 2025, with the low at 0.09% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.0%, with a median of 0.01% recorded in 2023.
  • Year-over-year, Return on Capital Employed rose 15bps in 2021 and then decreased -11bps in 2022.
  • Tracing TEVA's Return on Capital Employed over 5 years: stood at 0.05% in 2021, then tumbled by -244bps to 0.07% in 2022, then skyrocketed by 121bps to 0.01% in 2023, then crashed by -177bps to 0.01% in 2024, then skyrocketed by 835bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Return on Capital Employed are 0.08% (Q4 2025), 0.06% (Q3 2025), and 0.03% (Q2 2025).